Florida's Forfeiture Faction
Many of the dynamics of the debate on follow-on biologics have been forged by the fact that one of the senior Democrats on the House Energy and Commerce Committee, Rep. Anna Eshoo, represents a biotech hotspot, Palo Alto, Calif. The dynamics of the debate on brand-generic settlement seem also to be driven by a similar geographic issue - which generic firms are located in Florida.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth